Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation d'Une Stratégie de Programme Transfusionnel Par Erythraphérèse basée Sur un Algorithme d'Aide à la Prescription Transfusionnelle Chez Les Patients Adultes Drépanocytaires

NCT04076683 is registered in ClinicalTrials.gov with Etablissement Français du Sang as lead sponsor.

NCT NCT04076683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04076683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation d'Une Stratégie de Programme Transfusionnel Par Erythraphérèse basée Sur un Algorithme d'Aide à la Prescription Transfusionnelle Chez Les Patients Adultes Drépanocytaires
Lead sponsor
Etablissement Français du Sang
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2022
Completion date
November 30, 2023
Enrollment
65 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease